• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Trametinib

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
Labeling Sections with
Pharmacogenomic
Information
TrametinibOncologyBRAFBRAF V600E/K
mutation positive
Indications and Usage
Dosage and Administration
Adverse Reactions
Clinical Pharmacology
Clinical Studies
Patient Counseling Information

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling